Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2023-03-24 AGM Information
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
Proxy General Meeting 27 avril 2023 - FR- V11.pdf
AGM Information Classification · 99% confidence The document is explicitly titled "PROCURATION POUR L'ASSEMBLÉE GÉNÉRALE DES ACTIONNAIRES DU 27 AVRIL 2023" (Proxy for the General Shareholders' Meeting of April 27, 2023). It is a form for shareholders to appoint a proxy and provide voting instructions for specific agenda items, including the approval of annual accounts, remuneration reports, and director re-elections. This material is directly related to soliciting votes for a general meeting and providing the necessary documentation for shareholders to exercise their voting rights. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). Although it relates to an AGM, the document itself is the proxy form, not the AGM presentation (AGM-R) or the formal notice/results (DEF 14A/DVA).
2023-03-24 French
Proxy General Meeting 27 April 2023 - NL - V11.pdf
AGM Information Classification · 98% confidence The document is titled "VOLMACHT VOOR DE ALGEMENE VERGADERING VAN AANDEELHOUDERS VAN 27 APRIL 2023" (Proxy for the Annual General Meeting of Shareholders of April 27, 2023). It contains instructions for shareholders on how to appoint a proxy to vote on various agenda items, including the approval of the annual accounts, remuneration report, director appointments, and specific financing agreements (Change of Control clauses). This document is explicitly a proxy form or related material used to solicit votes for the Annual General Meeting (AGM). This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to request votes for meetings. While it discusses items typically found in an AGM, the document itself is the mechanism for voting representation, making PSI the most accurate classification over AGM-R (which is usually the presentation/minutes of the meeting itself).
2023-03-24 Dutch
ENG - Convening notice AGM 27 April 2023 - V11 - FINAL.pdf
AGM Information Classification · 99% confidence The document is explicitly titled "CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS" and details the agenda for a meeting scheduled for April 27, 2023. The agenda items cover the approval of annual accounts, remuneration reports, director appointments/renewals, and the approval of change of control clauses related to financing agreements, all of which are standard procedures for an Annual General Meeting (AGM). Although it discusses the approval of the remuneration report (related to DEF 14A) and the annual accounts (related to 10-K/AR), the document's primary function is to convene the shareholders for voting on these matters. Therefore, the most appropriate classification is AGM Information (AGM-R).
2023-03-24 English
FR - Convening notice AGM 27 April 2023 - V11 - FINAL.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "CONVOCATION A L'ASSEMBLEE GENERALE DES ACTIONNAIRES" (Notice of the General Shareholders' Meeting) and details the agenda items to be voted upon on Thursday, April 27, 2023. The agenda includes voting on the annual report, remuneration report, director discharges, director renewals/appointments, and approval of change-of-control clauses in financing agreements. This content is the formal notice and agenda for an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information).
2023-03-24 French
NL - Convening notice AGM 27 April 2023 - V11 - FINAL.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "OPROEPING TOT DE ALGEMENE VERGADERING VAN AANDEELHOUDERS" (Call for the General Meeting of Shareholders) and details the agenda items for the meeting scheduled for April 27, 2023. The agenda includes voting on the Annual Report, Remuneration Report, discharge of directors, appointment/re-appointment of directors, and approval of specific financing clauses (Change of Control clauses under Article 7:151 of the Belgian Companies Code). This content—a formal notice convening a shareholder meeting and outlining the resolutions to be voted upon—is the defining characteristic of materials related to an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R.
2023-03-24 Dutch
230303 - Acquisition of own shares_ENG (final) - Copy.pdf
Transaction in Own Shares Classification · 100% confidence The document explicitly details the 'Acquisition of own shares' by UCB SA/NV, providing specific dates, the number of shares repurchased, and the average price paid, all under the framework of its 'Share Repurchase Program 2023'. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category.
2023-03-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.